The Biology of Cancer - Vibrational Spectroscopy for Tissue Analysis - page 54

59. Weichselbaum, R. R., Becket M., and Diamond A. 1988. Some retinoblasto-
mas, osteosarcomas, and soft tissue sarcomas may share a common etiology.
Proceedings of the National Academy of Sciences USA 65, 2106-2109.
60. Ruggeri, B., Zhang S.Y., and Camaano, J. 1992. Human pancreatic carcino-
mas and cell lines reveal frequent and multiple alterations in the p53 and rb-1
tumour suppressor genes. Oncogenes 7, 1503-1511.
61. Lane, D. P. 1992. p53, guardian of the genome. Nature 358, 15-16.
62. Fermisco, J., Ozzane, B., and Stiles, C. 1985. Cancer Cells: Growth Factors and
Transformation. Cold Spring Harbor, New York 389-399.
63. John, P. C. L. 1981. The Cell Cycle . Cambridge, UK: Cambridge University Press.
64. Hutchison, C. 1995. Cell Cycle Control . New York: IRL Press.
65. Raven, P. H., Ray F. E., and Susan E. E. 2005. Biology of Plants , 7 th ed. New York:
W. H. Freeman and Company.
66. Sherr, C. J., and Roberts J. M., 1995. Inhibitors of mammalian g(1) cyclin-
dependant kinase. Genes Development 9, 1149-1163.
67. Almendral, J. M., Sommer D., Macdonaldbravo, H., et al. 1988. Complexity of
the early genetic response to growth: Factors in mouth fibroblasts. Molecular Cell
Biology 8, 2140-2148.
68. Zipfel, P. F., Irving, S. G., Kelly, K., et al. 1989. Complexity of the primary genetic
response to mitogenic activation of human T-cells. Molecular and Cellular Biology
9, 1041-1048.
69. Mayer, R. J., and Fujita, J. 2006. Gankyrin, the 26 S proteasome, the cell cycle and
cancer. Biochemical Society Transactions 34, 746-748.
70. Preetha, A., Huigol, N., and Banerjee, R. 2005. Interfacial properties as biophysi-
cal markers of cervical cancer. Biomedicine and Pharmacotherapy 59, 491-497.
71. Sok, M., Sentjurc, M., and Schara, M. 1999. Membrane fluidity characteristics of
human lung cancer. Cancer Letter 139, 215-220.
72. Sok, M., Sentjurc, M., Schara, M., Stare, J., and Rott, T. 2002. Cell membrane flu-
idity and prognosis of lung cancer. The Annals of Thoracic Surgery 73, 1576-1571.
73. Fu, L. W., Zhang, Y. M., Liang, Y. J., Yang, X. P., and Pan, Q. C. 2002. The multi-
drug resistance of tumour cells was reversed by tetrandrine in vitro and in xeno-
grafts derived from human breast adenocarcinoma. European Journal of Cancer
38, 418-426.
74. Coppe, J. P., Smith, A. P., and Desprez, P. 2003. Id proteins in epithelial cells.
Experimental Cell Research 285, 131-145.
75. Wong, Y. F., Cheung, T. H., Lo, K. W. K., et al. 2004. Protein profiling of cervical
cancer by protein-biochips: Proteomic scoring to discriminate cervical cancer
from normal cervix. Cancer Letters 211, 227-234.
76. Gam, L.-H., Leow, C.-H., Man, C. N., Gooi, B.-H., and Singh, M. 2006. Analysis
of differentially expressed proteins in cancerous and normal colonic tissues.
World Journal of Gastroenterology 12(31), 4973-4980.
77. Suresh, S. 2007. Biomechanics and biophysics of cancer cells. Acta Biomaterialia
3, 413-438.
78. Mehle, C., and Piatyszek, M. A., 1996. Telomerase activity in human renal cell
carcinoma. Oncogenes 13, 161-166.